Semaglutide

#Alcohol Use Disorder #Clinical trials #GLP-1 #Semaglutide #Wegovy #Weight loss

Weight-loss pill may quieten alcohol cravings

New research has shown that people taking oral semaglutide – the active ingredient used in Wegovy – experienced fewer heavy-drinking days, consumed fewer drinks when they did drink and reported weaker everyday cravings than those given a placebo. The eight-week randomised clinical trial involved 50 adults with moderate-to-severe alcohol use… Read More

#News